Home › NDC Lookup › RxCUI directory › RxCUI 1364435

Apixaban 2.5 MG Oral Tablet — RxCUI 1364435

RxNorm drug concept · Semantic clinical drug
RxCUI 1364435 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 31 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1364435
Official nameApixaban 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped31
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Apixaban: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Apixaban is a blood thinner prescribed to reduce the risk of stroke if you have a type of irregular heartbeat called atrial fibrillation. It's also used to treat or prevent dangero...
  • You can take apixaban with or without food — it doesn't make a difference to how it's absorbed. It's usually taken twice a day, so try to space your doses roughly 12 hours apart an...
  • Can I take apixaban with food, and does it matter what time of day I take it?
  • Since apixaban thins your blood, bleeding is the main side effect to stay alert to. Serious warning signs include unusual or heavy bruising, cuts that won't stop bleeding, pink or...
📖 Read our full Apixaban guide →

🕸️ Concept Web — How Apixaban 2.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Apixaban 2.5 MG Oral Tablet RxCUI 1364435

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Apixaban 1364430
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Eliquis 1364436
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Apixaban Oral Tablet 1364434
    • Apixaban Oral Product 1364432
    • Apixaban Pill 1364433
    • Apixaban Oral Tablet [Eliquis] 1364438
    • Eliquis Oral Product 1364439
    • Eliquis Pill 1364440
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Apixaban 2.5 MG SCDC · 1364431
  • Apixaban Oral Tablet SCDF · 1364434
  • Apixaban Oral Product SCDG · 1364432
  • Apixaban Pill SCDG · 1364433

Brand-Name Concepts

  • Apixaban 2.5 MG Oral Tablet [Eliquis] SBD · 1364441
  • Apixaban 2.5 MG [Eliquis] SBDC · 1364437
  • Apixaban Oral Tablet [Eliquis] SBDF · 1364438
  • Eliquis Oral Product SBDG · 1364439
  • Eliquis Pill SBDG · 1364440
  • Eliquis BN · 1364436

📦 FDA Products & Package NDCs

12 products · 31 package NDCs
31 package NDCs map to RxCUI 1364435 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-1721-01 10 BLISTER PACK in 1 CARTON (0115-1721-01) / 10 TABLET, FIL... Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
00115-1721-03 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0115-1721-03) Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
00115-1721-13 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0115-1721-13) Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
00115-1722-01 10 BLISTER PACK in 1 CARTON (0115-1722-01) / 10 TABLET, FIL... Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
00115-1722-03 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0115-1722-03) Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
00115-1722-13 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0115-1722-13) Apixaban Amneal Pharmaceuticals of New York LLC 2018-08-31
14445-0149-05 500 TABLET, FILM COATED in 1 BOTTLE (14445-149-05) apixaban Indoco Remedies Limited 2020-09-16
14445-0149-10 1 TABLET, FILM COATED in 1 CARTON (14445-149-10) apixaban Indoco Remedies Limited 2020-09-16
14445-0149-14 1 TABLET, FILM COATED in 1 CARTON (14445-149-14) apixaban Indoco Remedies Limited 2020-09-16
14445-0149-18 180 TABLET, FILM COATED in 1 BOTTLE (14445-149-18) apixaban Indoco Remedies Limited 2020-09-16
14445-0149-60 60 TABLET, FILM COATED in 1 BOTTLE (14445-149-60) apixaban Indoco Remedies Limited 2020-09-16
14445-0150-05 500 TABLET, FILM COATED in 1 BOTTLE (14445-150-05) apixaban Indoco Remedies Limited 2020-09-16
14445-0150-10 10 TABLET, FILM COATED in 1 BLISTER PACK (14445-150-10) apixaban Indoco Remedies Limited 2020-09-16
14445-0150-18 180 TABLET, FILM COATED in 1 BOTTLE (14445-150-18) apixaban Indoco Remedies Limited 2020-09-16
14445-0150-60 60 TABLET, FILM COATED in 1 BOTTLE (14445-150-60) apixaban Indoco Remedies Limited 2020-09-16
33342-0337-09 60 TABLET, FILM COATED in 1 BOTTLE (33342-337-09) Apixaban Macleods Pharmaceuticals Limited 2025-02-27
33342-0337-12 10 BLISTER PACK in 1 CARTON (33342-337-12) / 10 TABLET, FIL... Apixaban Macleods Pharmaceuticals Limited 2025-02-27
33342-0337-15 500 TABLET, FILM COATED in 1 BOTTLE (33342-337-15) Apixaban Macleods Pharmaceuticals Limited 2025-02-27
33342-0338-09 60 TABLET, FILM COATED in 1 BOTTLE (33342-338-09) Apixaban Macleods Pharmaceuticals Limited 2025-02-27
33342-0338-12 10 BLISTER PACK in 1 CARTON (33342-338-12) / 10 TABLET, FIL... Apixaban Macleods Pharmaceuticals Limited 2025-02-27
33342-0338-15 500 TABLET, FILM COATED in 1 BOTTLE (33342-338-15) Apixaban Macleods Pharmaceuticals Limited 2025-02-27
50090-1436-00 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-1436-0) ELIQUIS A-S Medication Solutions 2014-11-28
50090-1437-00 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-1437-0) ELIQUIS A-S Medication Solutions 2014-11-28
50090-6451-00 60 TABLET, FILM COATED in 1 BOTTLE (50090-6451-0) ELIQUIS A-S Medication Solutions 2023-04-24
55154-0612-00 10 BLISTER PACK in 1 BAG (55154-0612-0) / 1 TABLET, FILM CO... ELIQUIS Cardinal Health 107, LLC 2012-12-28
55154-0612-08 4140 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0612-8) ELIQUIS Cardinal Health 107, LLC 2012-12-28
55154-0613-00 10 BLISTER PACK in 1 BAG (55154-0613-0) / 1 TABLET, FILM CO... ELIQUIS Cardinal Health 107, LLC 2012-12-28
55154-0613-08 2040 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0613-8) ELIQUIS Cardinal Health 107, LLC 2012-12-28
71610-0811-42 1800 TABLET, FILM COATED in 1 BOTTLE (71610-811-42) ELIQUIS Aphena Pharma Solutions - Tennessee, LLC 2025-01-27
71610-0811-80 180 TABLET, FILM COATED in 1 BOTTLE (71610-811-80) ELIQUIS Aphena Pharma Solutions - Tennessee, LLC 2025-01-27
71610-0811-83 3600 TABLET, FILM COATED in 1 BOTTLE (71610-811-83) ELIQUIS Aphena Pharma Solutions - Tennessee, LLC 2024-03-28
Observed labelers: Indoco Remedies Limited (9) · Amneal Pharmaceuticals of New York LLC (6) · Macleods Pharmaceuticals Limited (6) · Cardinal Health 107, LLC (4) · A-S Medication Solutions (3) · Aphena Pharma Solutions - Tennessee, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.